Pfizer Seeks Green Light for Covid-19 Vaccine for Young Children
P.M. Edition for Oct. 7. Pfizer and its partner BioNTech are seeking authorization from federal health officials for their Covid-19 vaccine for children ages 5 to 11. That means a vaccine for that age group could be available within weeks. For some parents, that is welcome news. But others have some concerns. Health business editor Jonathan Rockoff joins host Annmarie Fertoli to discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices
